April 16, 2026
FOCUS on Mitochondrial Disease. Leigh syndrome (LS) is a mitochondrial disease characterized by neurodevelopmental regression and muscle weakness with early death following metabolic crises. In a […]
April 14, 2026
Focus Biomolecules will be exhibiting at the annual meeting of American Association for Cancer Research in San Diego, April 19 – 22. Stop by our booth […]
March 12, 2026
FOCUS on a New Pharma Success Story. Day One Biopharmaceuticals is only 8 years old, yet in that short period of time it bought the rights […]
March 4, 2026
Focus Biomolecules will be exhibiting at the annual meeting of the American Society for Biochemistry and Molecular Biology near Washington, DC, March 7 – 10. Stop […]
March 4, 2026
FOCUS on new drug approvals. On February 24th the FDA granted approval to Encorafenib (Braftovi, Array Biopharma, a subsidiary of Pfizer) in combination with cetuximab and […]
February 27, 2026
Will you be attending the AACR (American Association for Cancer Research) Annual Meeting 2026 in San Diego this April? Focus Biomolecules will be awarding two travel […]
February 19, 2026
FOCUS on new drug approvals. On February 12th the FDA granted approval for Acrotech Biopharma’s Difamilast (Adquey) for mild to moderate atopic dermatitis. The approval marks […]
February 13, 2026
FOCUS on Drug Repurposing. A study just published in Neuron suggests the HIV drug Maraviroc (a CCR5 antagonist) may be useful for the treatment of glioblastoma […]
February 11, 2026
FOCUS on Parkinson’s Disease: Y Xu and coworkers identified deubiquitinating enzyme USP25 as a susceptible locus for PD as just reported in PNAS. They showed that USP25 […]